Dr Vincent F Miscia, MD | |
300 Rocky Hill Road, Bridgewater, CT 06752-0004 | |
(860) 210-1948 | |
(860) 210-1951 |
Full Name | Dr Vincent F Miscia |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 300 Rocky Hill Road, Bridgewater, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942357488 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Vincent F Miscia, MD Po Box 4, 300 Rocky Hill Road, Bridgewater, CT 06752-0004 Ph: (860) 210-1948 | Dr Vincent F Miscia, MD 300 Rocky Hill Road, Bridgewater, CT 06752-0004 Ph: (860) 210-1948 |
News Archive
Exercise has long-been recommended as a cognitive-behavioral therapy for patients of depression, yet new evidence from the University of California of San Diego suggests that the COVID-19 pandemic changed the nature of the relationship between physical activity and mental health.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
A team of doctors from RUDN University with their Italian colleagues had studied the data of existing studies on the effect of endometriosis on pregnancy and childbirth and suggested ways to reduce obstetrical complications in women with this condition.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of a new Cooperative Research and Development Agreement with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens.
Researchers headed by Maria Macias an ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) and Joan Massagu-, a Howard Hughes Medical Institute investigator at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, have identified a new molecular mechanism that plays a crucial role in the control of the activation of certain genes associated with cancer.
› Verified 8 days ago